Healthcare Services

Nuclear Medicine Market Growth Outlook Indicating Expansion To $17.13 Billion By 2030

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Nuclear Medicine Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The rapid expansion of the nuclear medicine market has been observed in recent years. It is projected to increase from $10.18 billion in 2025 to $11.4 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.9%. The growth experienced in the historic period can be ascribed to factors such as limited access to nuclear imaging equipment, the high cost of radiopharmaceuticals, a lack of trained personnel, restricted hospital and diagnostic center infrastructure, and low patient awareness.

The nuclear medicine market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $17.13 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.7%. This anticipated expansion throughout the forecast period stems from factors such as a heightened need for sophisticated diagnostic and therapeutic methods, growing governmental efforts in cancer and cardiac treatment, wider implementation in hospitals and diagnostic centers, breakthroughs in radiopharmaceuticals and imaging technology, and greater patient knowledge coupled with increased healthcare spending. Key developments expected during this period encompass a greater acceptance of diagnostic imaging approaches, expanded application of therapeutic radiopharmaceuticals, heightened call for PET and SPECT scans, intensified concentration on oncology and cardiology uses, and more widespread deployment within hospitals and diagnostic facilities.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7485&type=smp

What Important Drivers Are Powering The Nuclear Medicine Market Growth?

The rising persistence and occurrence of cardiovascular disease (CVD) and cancer are projected to fuel the expansion of the nuclear medicine market. Cardiovascular diseases (CVDs) encompass various heart and blood vessel conditions, while cancer involves the uncontrolled proliferation of cells that can spread throughout the body. Nuclear cardiac imaging offers a rapid means for diagnosing heart ailments. Furthermore, nuclear medicine therapy provides a treatment approach for cancer, potentially used in conjunction with or following other treatments like surgery and chemotherapy. Consequently, the increasing persistence and occurrence of cardiovascular disease and cancer amplify the need for the nuclear medicine market. For example, in January 2023, the American Cancer Society Inc., a US-based non-profit health group, reported an estimated 1,958,310 new cancer cases to be diagnosed in the US, marking an increase from over 1,918,030 new cancer cases in 2022. Thus, the growing persistence and prevalence of cardiovascular diseases and cancer are propelling the nuclear medicine market.

What Segment Categories Are Evaluated In The Nuclear Medicine Market Study?

The nuclear medicine market covered in this report is segmented –

1) By Type: Diagnostic, Therapeutic

2) By Application: Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:

1) By Diagnostic: Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), Gamma Cameras

2) By Therapeutic: Radiopharmaceuticals For Targeted Therapy, Beta Emitters, Alpha Emitters, Radiosynovectomy Agents

Which Trends Are Influencing The Expansion Of The Nuclear Medicine Market?

Leading companies in the nootropics market are actively developing nootropics with multiple flavors, often as product line extensions within the nutraceutical sector, to bolster cognitive and physical health. A product line extension in nutraceuticals signifies a strategy where a firm introduces a new product or a variation within its existing health-focused brand collection, specifically in the nutraceutical domain, to address additional consumer requirements or broaden the spectrum of benefits. For example, in June 2023, Rollagranola, a food and beverage enterprise based in the UK, unveiled its Nootropics range, featuring four distinct flavors designed to satisfy both nutritional needs and taste preferences. This innovative collection includes Calm, Energize, Body and Soul, and Complete Vegan. Calm is formulated to encourage relaxation and alleviate stress, utilizing ingredients such as ashwagandha and matcha green tea. Energize provides a cappuccino and white chocolate blend aimed at improving focus and boosting energy, incorporating lion’s mane, caffeine, and panax ginseng. Body and Soul unites summer berries and walnuts to support overall physical and mental well-being, containing ingredients like creatine, maca, ginkgo, and panax ginseng. Lastly, Complete Vegan is a granola specifically crafted for vegans, supplying essential nutrients, pea protein, and key vitamins to mitigate deficiencies and enhance focus, memory, and mood.

Which Firms Are Competing In The Nuclear Medicine Market?

Major companies operating in the nuclear medicine market are Bracco Imaging S.P.A., Lantheus Medical Imaging Inc., NTP Radioisotopes SOC Ltd., Eckert & Ziegler Group, Jubilant Pharma LLC, Australian Nuclear Science & Technology Organisation, Cardinal Health Inc., GE Healthcare Technologies Inc., Curium Pharma, Advanced Accelerator Applications USA Inc., Nordion Inc., The Institute for Radioelements, Eczacibasi-Monrol Nuclear Products Co., Siemens Healthineers AG, Cambridge Isotope Laboratories Inc., Bayer AG, Triad Isotopes Inc., Mallinckrodt Pharmaceuticals plc, PharmaLogic Holdings Corp., Institute of Isotopes Co. Ltd., Sinotau Pharmaceuticals Limited, Isotopia Molecular Imaging Limited, SHINE Medical Technologies Inc., JSC Isotope Inc., NorthStar Medical Radioisotopes LLC, Global Medical Solutions LLC

Access The Complete Nuclear Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report

Which Geographic Region Represents The Largest Nuclear Medicine Market Share?

North America was the largest region in the nuclear medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Nuclear Medicine Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=7485&type=smp

Browse Through More Reports Similar to the Global Nuclear Medicine Market 2026, By The Business Research Company

Inotropic Agents Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/inotropic-agents-global-market-report

Orthobiologics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/orthobiologics-global-market-report

Spatial Omics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/spatial-omics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795